WST - CIK 0000105770
WEST PHARMACEUTICAL SERVICES INC (WST) reported net income of $493.70M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $493.70M | +0.2% |
| FY 2024 | $492.70M | -17.0% |
| FY 2023 | $593.40M | +1.3% |
| FY 2022 | $585.90M | -11.5% |
| FY 2021 | $661.80M | +91.2% |
| FY 2020 | $346.20M | +43.2% |
| FY 2019 | $241.70M | +16.8% |
| FY 2018 | $206.90M | +216.8% |
| FY 2010 |
WEST PHARMACEUTICAL SERVICES INC (WST) reported net income of $493.70M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2008 and fiscal 2025, WEST PHARMACEUTICAL SERVICES INC's net income grew from $86.00M to $493.70M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $65.30M |
| -10.1% |
| FY 2009 | $72.60M | -15.6% |
| FY 2008 | $86.00M | - |